Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Penn Dental Medicine Study Investigates Plant-encapsulated Delivery Platform for Oral Delivery of GLP-1 Drugs

prnewswire.com
NVO LLY

U.S. Pharmaceutical Market to Reach USD 965 Billion by 2035

globenewswire.com
ABT BIIB BMY GILD GSK LLY MRK NVS NVO PFE SNY

FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States

globenewswire.com
LLY NVO BMY AMGN AZN PFE ALT

HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare

prnewswire.com
PFE MRNA NVS LLY

Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035

globenewswire.com
ALXO MRK AZN LLY

Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

globenewswire.com
SNY ABBV LLY PFE

Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

prnewswire.com
LLY

Spherix Global Insights Finds Specialty Split in Perceptions of Direct-to-Patient Platforms for Obesity Treatment

globenewswire.com
LLY NVO

Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
PACB BRKR PFE AMGN LLY TMO

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

globenewswire.com
LLY